Literature DB >> 31207227

Clonal Expansion of Second-Hit Cells with Somatic Recombinations or C>T Transitions Form Porokeratosis in MVD or MVK Mutant Heterozygotes.

Akiharu Kubo1, Takashi Sasaki2, Hisato Suzuki3, Aiko Shiohama4, Satomi Aoki5, Showbu Sato5, Harumi Fujita4, Noriko Ono5, Noriko Umegaki-Arao5, Tomoko Kawai6, Kazuhiko Nakabayashi6, Kenichiro Hata6, Daisuke Yamada7, Yoichi Matsubara8, Kenjiro Kosaki3, Masayuki Amagai9.   

Abstract

Patients with disseminated superficial actinic porokeratosis (DSAP) and linear porokeratosis (LP) exhibit monoallelic germline mutations in genes encoding mevalonate pathway enzymes, such as MVD or MVK. Here, we showed that each skin lesion of DSAP exhibited an individual second hit genetic change in the wild-type allele of the corresponding gene specifically in the epidermis, indicating that a postnatal second hit triggering biallelic deficiency of the gene is required for porokeratosis to develop. Most skin lesions exhibited one of two principal second hits, either somatic homologous recombinations rendering the monoallelic mutation biallelic or C>T transition mutations in the wild-type allele. The second hits differed among DSAP lesions but were identical in those of congenital LP, suggesting that DSAP is attributable to sporadic postnatal second hits and congenital LP to a single second hit in the embryonic period. In the characteristic annular skin lesions of DSAP, the central epidermis featured mostly second hit keratinocytes, and that of the annular ring featured a mixture of such cells and naïve keratinocytes, implying that each lesion reflects the clonal expansion of single second hit keratinocytes. DSAP is therefore a benign intraepidermal neoplasia, which can be included in the genetic tumor disorders explicable by Knudson's two-hit hypothesis.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31207227     DOI: 10.1016/j.jid.2019.05.020

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  10 in total

Review 1.  Molecular mechanisms of phenotypic variability in monogenic autoinflammatory diseases.

Authors:  Ivona Aksentijevich; Oskar Schnappauf
Journal:  Nat Rev Rheumatol       Date:  2021-05-25       Impact factor: 20.543

2.  Topical cholesterol/lovastatin for the treatment of porokeratosis: A pathogenesis-directed therapy.

Authors:  Lihi Atzmony; Young H Lim; Claire Hamilton; Jonathan S Leventhal; Annette Wagner; Amy S Paller; Keith A Choate
Journal:  J Am Acad Dermatol       Date:  2019-08-23       Impact factor: 11.527

3.  [Linear porokeratosis with severe itch accompanied by lesional upregulation of interleukin 31, thymic stromal lymphopoietin, and periostin].

Authors:  Takashi Hashimoto; Yoshihiro Moriyama; Takahiro Satoh
Journal:  Eur J Dermatol       Date:  2021-08-26       Impact factor: 2.805

Review 4.  Twists and turns of the genetic story of mevalonate kinase-associated diseases: A review.

Authors:  Isabelle Touitou
Journal:  Genes Dis       Date:  2021-06-09

5.  A preliminary study of peripheral T-cell subsets in porokeratosis patients with MVK or MVD variants.

Authors:  L Tao; Y K Huang; K X Yan; C H Li; L Shen; Z H Zhang
Journal:  Skin Health Dis       Date:  2021-12-16

6.  Second-Hit Somatic Mutations in Mevalonate Pathway Genes Underlie Porokeratosis.

Authors:  Lihi Atzmony; Keith A Choate
Journal:  J Invest Dermatol       Date:  2019-12       Impact factor: 8.551

7.  Two Cases of Porokeratosis with MVD Mutations, in Association with Bullous Pemphigoid.

Authors:  Yuki Arisawa; Yasutoshi Ito; Kana Tanahashi; Yoshinao Muro; Tomoo Ogi; Takuya Takeichi; Masashi Akiyama
Journal:  Acta Derm Venereol       Date:  2021-03-31       Impact factor: 3.875

8.  Porokeratosis Plantaris, Palmaris et Disseminata Caused by Con- genital Pathogenic Variants in the MVD Gene and Loss of Hetero-zygosity in Affected Skin.

Authors:  Sabine Jägle; Hazem A Juratli; Geoffroy Hickman; Kira Süssmuth; Maria C Boente; Julia Kopp; Peter Kirchmeier; Andreas Zimmer; Rudolf Happle; Emmanuelle Bourrat; Henning Hamm; Judith Fischer
Journal:  Acta Derm Venereol       Date:  2021-02-16       Impact factor: 3.875

Review 9.  Compromised Protein Prenylation as Pathogenic Mechanism in Mevalonate Kinase Deficiency.

Authors:  Frouwkje A Politiek; Hans R Waterham
Journal:  Front Immunol       Date:  2021-09-03       Impact factor: 7.561

10.  Disseminated Superficial Actinic Porokeratosis (DSAP): A Case Report Highlighting the Clinical, Dermatoscopic, and Pathology Features of the Condition.

Authors:  Muhammad Umer Waqar; Philip R Cohen; Simona Fratila
Journal:  Cureus       Date:  2022-07-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.